Alibaba Health Information Technology Limited (ALBBY)

Market Cap	7.37B -33.3%
Revenue (ttm)	4.97B +12.0%
Net Income	280.71M +35.2%
EPS	0.02 +34.6%
Shares Out	n/a
PE Ratio	26.24
Forward PE	21.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,634
Open	9.75
Previous Close	9.48
Day's Range	9.27 - 9.75
52-Week Range	8.95 - 19.45
Beta	1.59
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About ALBBY

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,429
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALBBY

Financial Performance

In fiscal year 2026, ALBBY's revenue was 34.26 billion, an increase of 11.95% compared to the previous year's 30.60 billion. Earnings were 1.94 billion, an increase of 35.17%.

Financial numbers in CNY